[wiggles_md]

There isn’t enough information in the linked article to say how unique or important these particular cells are or how difficult they would be to replicate. On the more valuable end could be cells provided by a company for testing (maybe transformed to express some sort of protein they’ve created), or primary cells (isolated from an organism) that are unique in some way, or hybridomas that produce monoclonal antibodies for something druggable or diagnostically relevant.

The Boston Herald article linked by another commentator suggests that in at least one element this case fits the pattern of others that have been appearing: the accused is receiving funds from the Chinese government under an ostensible scholar program. In some of the other cases, such as with the Thousand Talents program, the scholars signed contracts that agreed to disclose or assign IP only to the Chinese institutions, conceal the source of funding for studies (both to journals or funding agencies), or agree to work at the Chinese institutions in excess of the norms for visiting appointments. The Thousand Talents program and others like it are a coordinated, calculated, and deliberate effort run by the Chinese government, not the accidental missteps of some aloof academics.

[knzhou]

Honestly, that just sounds like the usual rules for academic funding, phrased in a conspiratorial way. Would you also call NSF funding "a coordinated, calculated, and deliberate effort run by the American government"? Is science good for nothing but proxy war to you?

[yorwba]

> conceal the source of funding for studies (both to journals or funding agencies)

doesn't sound like the usual rules for academic funding. I heavily doubt whether the Thousand Talents program really has such a rule. It's the exact opposite of what organizations funding scientific research usually want: getting their name acknowledged in as many papers in prestigious journals as possible, in order to demonstrate success.